MyPharmacy+

Fertipreg M Tablet

Manufactured By Estragen Pharma

Salt Synonyms

Rs. 465.50

MRP 490.00

(5% OFF)

Includes all taxes

Package SIZE

strip of 10 tablets

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Fertipreg M Tablet

Uses / Indications:

Use as directed by a healthcare professional

Introduction:

Fertipreg M Tablet is a health supplement used for the treatment of iron and vitamin deficiencies. Fertipreg M Tablet may help address deficiencies in iron and vitamins which are essential for various bodily functions.

How to use:

Fertipreg M Tablet may provide nutritional support by supplying essential vitamins minerals and antioxidants to the body|Astaxanthin and Lycopene present in Fertipreg M Tablet are known for their antioxidant properties. Antioxidants help protect the body's cells from damage caused by free radicals|Fertipreg M Tablet may help in the treatment of iron and vitamin deficiencies which can be beneficial for individuals with anaemia or other related conditions

Description:

Supports immune function|Has antioxidant effects|Improves energy levels|Prevents oxidative stress

Benefits:

Safety Advise:

Read the label carefully before use|Alcohol consumption should be avoided during medication|Keep out of reach of children

Fertipreg M Tablet

Manufactured By Estragen Pharma

Salt Synonyms

Rs. 465.50

MRP 490.00

Includes all taxes

Package SIZE

Available Substitutes

1-CC-FM Tablet

Azure Pharmaceuticals

1 Tree Milk Thistle Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Sleep Right Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Vita Gold Tablet

Nextgen Healthcare

1 Vita Oral Drops

Nextgen Healthcare

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: